Product Images Topiramate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Topiramate NDC 67877-833 by Ascend Laboratories, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
topi-fig-1 - topi fig 1
This is a comparison between two groups receiving different doses of Topiramate - 50 mg/day and 400 mg/day. The study illustrates the cumulative rates for time to the first seizure over a period of 500 days. The data shows significant differences between the two groups (p=0.0002).*
topi-fig-2 - topi fig 2
This is an evaluation comparing the effects of different doses of Topiramate and a placebo on a group of participants. The study includes various dosages of Topiramate: 50 mg/day, 100 mg/day, and 200 mg/day compared to a placebo group. The data seems to include the number of participants in each group and some statistical results denoted by symbols such as "p<0.010" and "p<0.001" indicating significance levels. The study likely analyzes the rate of change from baseline to the double-blind phase in response to the different treatments.*
Topiramate 240 mL Carton Label - topi fig 4
topi-stru - topi stru
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
